Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
28 Februari 2026, 14:16:03
Nephritic syndrome
23 Novemba 2020, 11:53:17
Nephritic syndrome refers to a group of glomerular disorders characterized by inflammation of the glomeruli, resulting in leakage of blood and moderate amounts of protein into urine, reduced glomerular filtration rate (GFR), and fluid retention.
Glomerular disease may arise from:
Primary renal disease, or
Secondary systemic disorders affecting the kidneys.
Unlike nephrotic syndrome, nephritic syndrome is primarily an inflammatory process, often presenting acutely and potentially progressing to acute kidney injury (AKI) if not promptly managed.
Pathophysiology
Inflammation of the glomerular capillary walls leads to:
Damage to glomerular filtration barrier
Leakage of red blood cells → haematuria
Reduced filtration → decreased GFR
Sodium and water retention
Hypertension and oedema
Immune-mediated injury is the most common mechanism involving:
Immune complex deposition
Complement activation
Cellular inflammation
Common Causes
Primary Glomerular Diseases
Acute post-streptococcal glomerulonephritis (APSGN)
IgA nephropathy
Rapidly progressive glomerulonephritis
Membranoproliferative glomerulonephritis
Secondary Causes
Systemic lupus erythematosus
Vasculitis
Infective endocarditis
Hepatitis B or C infection
Henoch–Schönlein purpura
Goodpasture syndrome
Risk Factors
Recent streptococcal throat or skin infection
Autoimmune diseases
Chronic infections
Genetic susceptibility
Male sex (some forms)
Childhood or young adulthood
Exposure to nephrotoxic agents
Signs and Symptoms
Urinary Manifestations
Cola-colored or smoky urine
Visible or microscopic haematuria
Mild to moderate proteinuria
Reduced urine output (oliguria)
Fluid Retention Features
Periorbital oedema
Peripheral oedema
Rapid weight gain
Systemic Features
Hypertension
Fatigue
Headache
Shortness of breath
Nausea and vomiting
Severe Presentations
Pulmonary oedema
Hypertensive emergency
Acute kidney injury
Encephalopathy
Diagnostic Criteria
Diagnosis is based on clinical and laboratory findings:
Haematuria
Proteinuria
Reduced GFR or rising serum creatinine
Hypertension
Oedema
Investigations
Baseline Investigations
Renal function tests (urea, creatinine, electrolytes)
Urinalysis (RBCs, protein, casts)
Urine microscopy (RBC casts)
Urine culture
Complete blood count
Immunological and Etiological Tests
(Usually performed at tertiary level)
Complement levels (C3, C4)
Antistreptolysin O titre (ASO)
ANA and anti-dsDNA
ANCA
Anti-GBM antibodies
Hepatitis B and C screening
HIV testing
Imaging
Renal ultrasound (kidney size and obstruction)
Definitive Diagnosis
Renal biopsy when:
Rapid deterioration of renal function
Unclear diagnosis
Suspected rapidly progressive glomerulonephritis
Adult-onset nephritic syndrome
Important Note:Definitive treatment depends entirely on identifying the underlying cause.
Management
Management focuses on:
Stabilization
Control of fluid overload
Blood pressure management
Treatment of underlying disease
Prevention of renal failure
Pharmacological Management
1. Fluid Overload
Furosemide 80 mg IV bolus
May repeat depending on response
2. Hypertension Management
If:
Diastolic BP >100 mmHgOR
Systolic BP >150 mmHg
→ Amlodipine 5 mg orally
Additional antihypertensives may be required under specialist care.
3. Cause-Specific Therapy (Specialist Guided)
May include:
Antibiotics (post-infectious causes)
Corticosteroids
Immunosuppressants
Plasmapheresis (severe immune disease)
ACE inhibitors/ARBs after stabilization
4. Management of Complications
Dialysis for severe renal failure
Treatment of hyperkalaemia
Management of pulmonary oedema
Non-Pharmacological Management
Administer oxygen if respiratory distress present
Nurse patient in semi-Fowler’s position
Strict salt restriction
Restrict potassium-containing foods
Fluid restriction:
10 mL/kg/day + visible fluid losses
Daily weight monitoring
Input–output chart monitoring
Avoid nephrotoxic medications
Complications
Acute kidney injury
Chronic kidney disease
Hypertensive crisis
Pulmonary oedema
Hyperkalaemia
Uraemia
End-stage renal disease
Prevention
Preventive strategies include:
Early treatment of streptococcal infections
Control of autoimmune diseases
Infection prevention
Avoidance of nephrotoxic drugs
Blood pressure control
Regular monitoring in high-risk patients
Early referral to specialist care
Referral Criteria
Immediate referral to nephrologist or tertiary hospital if:
Rapid decline in renal function
Severe hypertension
Oliguria or anuria
Pulmonary oedema
Suspected rapidly progressive glomerulonephritis
Electrolyte imbalance
Need for renal biopsy or dialysis
Patient Education
Patients and caregivers should be advised to:
Monitor urine color and output
Restrict salt intake
Adhere strictly to medications
Seek urgent care for breathlessness or reduced urine
Avoid herbal or over-the-counter nephrotoxic drugs
Attend follow-up renal assessments
Prognosis
Outcome varies depending on cause:
Post-streptococcal nephritis → usually good recovery (especially in children)
Autoimmune nephritis → variable progression
Rapidly progressive forms → may lead to permanent renal failure without early treatment
References
KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl. 2021;11(3):1-150.
Couser WG. Glomerulonephritis. Lancet. 2012;379(9813):331-340.
Floege J, Amann K. Primary glomerulonephritides. Lancet. 2016;387:2036-2048.
Johnson RJ, Feehally J, Floege J. Comprehensive Clinical Nephrology. 6th ed. Elsevier; 2019.
KDOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation and Management. Am J Kidney Dis. 2013;63(5 Suppl 2):S1-S150.
Rodriguez-Iturbe B, Haas M. Post-streptococcal glomerulonephritis. N Engl J Med. 2017;376:954-963.
Imeandikwa:
